16 Feb [Health Canada] National Strategy for High-Cost Drugs for Rare Diseases Online Engagement (Deadline: March 26th, 2021)

Health Canada is seeking feedback from Canadians to create a national strategy on high-cost drugs for rare diseases. This engagement is now open and will close on March 26th, 2021. You can learn more about this engagement and how to participate here.

You are invited to read the discussion paper, Building a National Strategy for High-Cost Drugs for Rare Diseases: A Discussion Paper for Engaging Canadians, which describes key considerations and questions for developing a national strategy for high-cost drugs for rare diseases.

Using the discussion paper as a guide, you can provide feedback in the following ways:

  • Complete the online questionnaire
  • Send a written submission via email (hc.opms-bsgpp.sc@canada.ca) or mail (Office of Pharmaceuticals Management Strategies, Strategic Policy Branch, Health Canada, Brooke Claxton Building, 70 Colombine Driveway, Ottawa, ON K1A 0K9)
  • Participate in a virtual public town hall

For more information, please visit:

Health Canada – National Strategy for High-Cost Drugs for Rare Diseases Online Engagement